You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 109 No. 11, November 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  AMERICAN SOCIETY FOR HEAD AND NECK SURGERY MEETING
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

The Treatment of Differentiated Carcinoma of the Thyroid Gland

Selective Management?

Oscar M. Guillamondegui, MD; Raouf A. Mikhail, MD

Arch Otolaryngol. 1983;109(11):743-745.


Abstract

• Two hundred thirty patients with differentiated carcinoma of the thyroid gland received definitive treatment at the University of Texas M. D. Anderson Hospital and Tumor Institute (MDAH), Houston, from January 1960 through December 1975. Two thirds of these patients were women, and 127 of these female patients (55%) had not had any previous treatment. The mean follow-up period was 11.8 years. The vast majority of patients (80%) had mixed papillary and follicular cancers; 104 patients were seen with cervical metastases. Overall absolute survival was 72.6%. The prognosis was more favorable in the female patients and those persons who were treated solely at MDAH. In 4.4% of those patients treated with a total thyroidectomy, the cancer recurred locally. Of those whose operation was only a lobectomy, local recurrence developed in 10.7%. Several adverse prognostic factors were identified in this group of patients. This analysis would suggest the need for a more selective approach to the surgical treatment of this disease. Differentiated cancer of the thyroid gland affects a heterogeneous group of patients and also appears with varied clinical and anatomic manifestations.

(Arch Otolaryngol 1983;109:743-745)



Author Affiliations

From the Department of Head and Neck Surgery, University of Texas M. D. Anderson Hospital and Tumor Institute, Houston. Dr Mikhail is a fellow of Head and Neck Surgery.


Footnotes

Accepted for publication July 13, 1983.

Read in part before the American Society of Head and Neck Surgeons, Palm Springs, Calif, March 10, 1983.

Reprints not available



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prognostic Factors in Patients Dying of Well-Differentiated Thyroid Cancer
Beenken et al.
Arch Otolaryngol Head Neck Surg 1989;115:326-330.
ABSTRACT  

Resident's Page
FECHNER
Arch Otolaryngol Head Neck Surg 1988;114:684-687.
ABSTRACT  

Radical Operation for Thyroid Carcinoma Invading the Trachea
Nakao et al.
Arch Surg 1984;119:1046-1049.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.